A survey study to detect early cognitive decline

Completed

• Conditions: HEALTHY

• Registration Number: CTRI/2020/12/029941
• Lead Sponsor: Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital Hassan

Brief Summary

The study will be a cross-sectional study among individuals fulfilling the inclusion criteria. After screening each subject who are willing to sign the informed consent, their cognition will be assessed using SLUMS (Saint Louis University Mental Status) Exam. The SLUMS consists of 11 items, and measures aspects of cognition that include [orientation](https://www.verywellhealth.com/what-is-orientation-and-how-is-it-affected-by-dementia-98571), [short-term memory](https://www.verywellhealth.com/short-term-memory-affected-by-alzheimers-98569), calculations, the naming of animals, the [clock drawing](https://www.verywellhealth.com/the-clock-drawing-test-98619) test and recognition of geometric figures. Scores range from 0 to 30. In a person with a high school education, scores of 27 to 30 are considered normal, scores between 20 and 27 suggest a mild neuro-cognitive disorder, scores between 1 to 19 indicate dementia. In a person with less than high school education, scores between 20 to 30 are considered normal, scores between 14 to 19 suggest a mild neuro-cognitive disorder and scores between 1-14 indicate dementia. The data so collected will be classified, analyzed, and interpreted using suitable statistical methods.

Detailed Description

Not available

Study Timeline

• Study Start: 2020-12-25
• Study Completion: 2022-02-15
• Last Update Posted: 2023-02-14

Recruitment & Eligibility

• Status: Completed
• Sex: All
• Target Recruitment: 250

Inclusion Criteria

• ï‚· Subjects willing to sign the informed consent form.
• ï‚· Apparently physically and mentally healthy subjects.
• ï‚· Subjects who are literate.

Exclusion Criteria

• Known case of any major psychiatric illnesses.
• ï‚· Known case of Parkinson’s disease, stroke or epilepsy.
• ï‚· Subjects with known history of uncontrolled diabetes mellitus, hypertension or other metabolic conditions.
• ï‚· Subjects under the influence of psychoactive substance.

Study & Design

• Study Type: Observational
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
To assess early cognitive decline in middle age	6 months

Secondary Outcome Measures

Name	Time	Method
HELPS IN EARLY INTERVENTION TO PREVENT MILD COGNITIVE IMPAIRMENT AND ALZHIMERS DISEASE	2 YEARS

Trial Locations

Locations (1)

Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital; 🇮🇳 Hassan, KARNATAKA, India

Sri Dharmasthala Manjunatheshwara College of Ayurveda and Hospital

🇮🇳Hassan, KARNATAKA, India

Dr Malavika B

Principal investigator

9980072909

malavikablk@gmail.com